	普通股股本		日
Akebia Therapeutics	USD 265.42M	199K	2025-12
Alaunos Therapeutics	USD 2.38M	172K	2026-03
Clinuvel Pharmaceuticals	AUD 50.2M	77.11K	2025-12
Dianthus Therapeutics	USD 54.58M	11.36M	2026-03
Genetic Signatures	AUD 227.14M	0	2025-12
Ionis Pharmaceuticals	USD 165.9M	3.93M	2026-03
Medical Developments International	AUD 112.66M	2.35M	2025-12
Neuren Pharmaceuticals	AUD 126.64M	38.63M	2025-12
Organon & Co	USD 262.65M	2.33M	2026-03
Paradigm Biopharmaceuticals	AUD 428.52M	39.09M	2025-12
PYC Therapeutics	AUD 597.24M	366.66M	2025-12
Starpharma Holdings	AUD 419.92M	179.17M	2025-12
Tectonic Therapeutic	USD 18.83M	92.19K	2026-03
Telix Pharmaceuticals	AUD 338.78M	379K	2025-12
Viatris	USD 1.16B	5.27M	2026-03
Xeris Pharmaceuticals	USD 172.56M	6.34M	2026-03